30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Welborn, Jr., John Lee

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 40% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Welborn, Jr., John Lee's trades of HLS Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-08 2024-12-31
B Purchase
69,409 +21.1%
417.99
CA$686,837 		69,409 +21.1% 417.99 CA$686,837
2024-12-16 2024-12-12
B Purchase
24,222 -36.0%
85.09
CA$4,477,995 		24,222 -36.0% 85.09 CA$4,477,995
2023-06-12 2023-06-08
B Purchase
72,065
387.77
CA$738,618 		72,065 387.77 CA$738,618